Fan-Favorite Snack Recalled Across Multiple States For a Life-Threatening Reason—Here's What to Know
The last thing anyone wants is to find out a favorite snack has been recalled. But the reality is, even the most familiar products can fall victim to mislabeling, contamination, or packaging issues. And when something on store shelves ends up compromised, it's on us to stay alert—because no one wants a recall lurking in their pantry.
Last week, Meijer issued a recall on certain packages of Frederik's Dark Chocolate Almonds because they contain undeclared cashews. According to the U.S. Food and Drug Administration (FDA), the label doesn't mention cashews at all—meaning anyone with a cashew allergy or sensitivity could be at risk for a serious, potentially life-threatening reaction if they eat them.
😋😋SIGN UP to get delicious recipes, handy kitchen hacks & more in our daily Pop Kitchen newsletter🍳🍔
The recall was sparked by a customer who flagged the issue after personally receiving the product. Once notified, Meijer acted quickly, working with the FDA to address the problem and get the affected packages off shelves and out of consumers' hands.
The recall includes Frederik's Dark Chocolate Almonds in black stand-up pouches sold at Meijer stores in Michigan, Indiana, Illinois, Ohio, Kentucky, and Wisconsin with sell-by dates of 05/07/2026 or 05/28/2026. Also affected are 8-count, 1.5-ounce multipacks dated 05/05/2026.As of June 16, Meijer has not received any reports of illness linked to the recall. However, the brand has shared the following product details to help consumers identify the affected packages both at home and on store shelves:
Frederik's by Meijer Dark Chocolate Almonds (12 oz.)UPC: 7-08820-68730-1, Sell By Dates: 05/07/2026, 05/28/2026
Frederik's Dark Chocolate Almonds 8-count 1.5 oz.UPC: 7-19283-11923-0, Sell By Date: 05/05/2026
As mentioned earlier, consumers with cashew allergies or sensitivities are most at risk. If you have any of the recalled products, Meijer urges you not to consume them. Instead, return the item to customer service at your local Meijer for a full refund. For questions about the recall, contact Meijer at 800-543-3704 between 7am and 1am EDT, Monday through Friday. If you have health concerns, reach out to your primary care provider.Fan-Favorite Snack Recalled Across Multiple States For a Life-Threatening Reason—Here's What to Know first appeared on Parade on Jun 17, 2025
This story was originally reported by Parade on Jun 17, 2025, where it first appeared.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
CRISPR and Lab-on-a-Chip Technologies Set to Revolutionize Pathogen Detection
The Global Food Pathogen Testing Market, valued at USD 10 billion in 2025, is projected to grow at a CAGR of 10%, reaching USD 23.5 billion by 2034. Growing food safety concerns and advancements in rapid testing methods, AI, and blockchain are driving this expansion, optimizing food supply chain transparency. Food Pathogen Testing Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Food Pathogen Testing Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges" report has been added to Food Pathogen Testing Market is valued at USD 10 billion in 2025. Further, the market is expected to grow at a CAGR of 10% to reach USD 23.5 billion by 2034. The Food Pathogen Testing Market is expanding rapidly as global food safety concerns continue to intensify. With rising instances of foodborne illnesses and outbreaks caused by bacteria such as Salmonella, Listeria, and E. coli, food manufacturers and regulatory authorities are prioritizing stringent testing protocols. Food pathogen testing plays a crucial role in ensuring the safety and quality of food products by detecting harmful microorganisms at various stages of production, processing, and distribution. Regulatory frameworks across regions, including the FDA's Food Safety Modernization Act (FSMA) in the U.S. and the European Union's strict food safety directives, are pushing companies to adopt advanced testing in rapid testing methods, including polymerase chain reaction (PCR) and immunoassay-based techniques, are enabling faster and more accurate pathogen detection. Additionally, the growing consumption of processed and packaged foods, along with increased global trade in perishable goods, is further propelling market demand. As food safety regulations become stricter worldwide, investment in food pathogen testing technologies and automation is expected to grow 2024, the Food Pathogen Testing Market has witnessed several key advancements driven by the growing emphasis on foodborne disease prevention. The demand for rapid and automated testing solutions has increased, with food manufacturers investing in next-generation molecular diagnostics and biosensors to achieve quicker turnaround times. AI-driven predictive analytics are being integrated into testing processes to enhance contamination risk assessments and prevent outbreaks before they occur. Regulatory bodies worldwide have intensified surveillance and enforcement, leading to a higher rate of recalls and penalties for expansion of microbiological testing services in developing economies, particularly in Asia-Pacific and Latin America, has also gained momentum due to increased food exports and a growing middle-class population demanding higher food safety standards. Meanwhile, the adoption of blockchain technology in food supply chains is improving traceability and ensuring transparency in pathogen testing, allowing for swift action in case of contamination. The market is also experiencing a shift toward portable testing kits that enable on-site detection, reducing dependency on centralized ahead to 2025 and beyond, the Food Pathogen Testing Market is expected to see further advancements in automation, precision, and regulatory alignment. AI and machine learning will play a more significant role in predictive food safety monitoring, helping manufacturers identify contamination risks before they escalate into widespread issues. The development of CRISPR-based diagnostics is set to revolutionize pathogen detection by providing ultra-sensitive and rapid testing solutions. Additionally, the rise of lab-on-a-chip technology will enable decentralized testing, making food safety monitoring more accessible and the increasing focus on sustainability, manufacturers will also seek eco-friendly testing solutions that minimize chemical waste and energy consumption. Governments and international organizations will likely standardize food safety regulations further, ensuring consistency across borders and streamlining compliance processes. As food production scales up to meet global demand, investments in robust pathogen testing infrastructure will become essential for ensuring public health and maintaining consumer trust in food Trends in the Food Pathogen Testing Market Adoption of AI and Big Data Analytics: AI-driven predictive modeling is being integrated into pathogen testing to analyze contamination patterns, optimize food safety protocols, and minimize risks before they lead to outbreaks. Rise of Rapid and Portable Testing Solutions: The demand for on-site pathogen testing kits is increasing, enabling food manufacturers and regulators to conduct immediate contamination assessments and reduce response times. Integration of Blockchain in Food Safety: Blockchain technology is enhancing traceability and transparency in food supply chains, ensuring accurate record-keeping and quick identification of contamination sources. Expansion of CRISPR-Based Pathogen Detection: Emerging CRISPR diagnostic technologies are offering ultra-fast and precise detection of harmful foodborne pathogens, promising a new era of molecular food safety testing. Growth of Outsourced Testing Services: Many food companies are partnering with third-party laboratories for pathogen testing, ensuring compliance with evolving regulatory requirements while reducing in-house testing costs. Key Market Drivers Increasing Foodborne Illness Outbreaks: Rising global cases of foodborne diseases are driving the demand for stringent pathogen testing measures to ensure consumer safety and prevent large-scale outbreaks. Stringent Government Regulations: Enhanced regulatory frameworks across regions are compelling food manufacturers to comply with mandatory pathogen testing standards, increasing market growth. Surge in Packaged and Processed Food Consumption: The growing consumption of ready-to-eat and processed foods necessitates rigorous testing to ensure microbiological safety and extend shelf life. Technological Advancements in Testing Methods: Innovations in molecular diagnostics, biosensors, and AI-powered analytics are improving pathogen detection efficiency, making testing faster and more reliable. Key Market Challenge High Cost of Advanced Testing Technologies: The implementation of sophisticated pathogen testing solutions, such as molecular diagnostics and AI-driven analytics, involves significant investment, posing challenges for small and mid-sized food businesses. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $10 Billion Forecasted Market Value (USD) by 2034 $23.5 Billion Compound Annual Growth Rate 10.0% Regions Covered Global Companies Featured Bureau Veritas SA Lloyd's Register Quality Assurance Limited Intertek Group plc Asurequality Ltd. Genevac Ltd. Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Merck Co. & KGaA Neogen Corporation bioMerieux SA Agilent Technologies Inc. Qiagen NV Shimadzu Corporation SGS Societe Generale de Surveillance SA Genetic Id Na Inc. RapidBio Systems Inc. Merieux NutriSciences Corp. FoodChain ID Inc. Ring Biotechnology Co. Ltd. Genon Laboratories Ltd. PerkinElmer Inc. Randox Food Diagnostics Ltd. Omega Diagnostics Group plc Romer Labs Inc. Eurofins Scientific SE Charm Sciences Inc. Hygiena LLC MilliporeSigma Hardy Diagnostics Luminex Corporation Market Segmentation By Type Salmonella Listeria Other Pathogens By Technology Traditional Rapid Immunoassay Convenience Based PCR Other Technologies By Application Meat And Poultry Fruits And Vegetables Dairy Other Applications By Sales Channel OEM Aftermarket By Geography North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Food Pathogen Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
GE HealthCare's Vizamyl Receives Expanded FDA Approval for Quantitative Alzheimer's Amyloid Detection
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June 24, 2025, GE HealthCare announced that the US FDA approved an updated label for its Vizamyl (flutemetamol F 18 injection) PET imaging agent, which is used for beta-amyloid detection. The immediate update expands the agent's indications, which allows for quantitative analysis of Vizamyl scans, and removes several prior limitations. Previously, amyloid diagnostics like Vizamyl provided a visual assessment of amyloid plaque in the brain. With the new label, clinicians can now use quantitative analysis software to objectively calculate amyloid load. A radiologist in a lab examining a computed tomography scan of a patient. The removal of the therapy monitoring limitation means Vizamyl can now be used to determine if amyloid plaque levels have sufficiently reduced to consider discontinuing therapy. The updated label also explicitly indicates Vizamyl's use for selecting patients eligible for anti-amyloid therapy. Vizamyl was initially approved in 2013 to estimate beta-amyloid neuritic plaque density in adults with cognitive impairment. GE HealthCare Technologies Inc. (NASDAQ:GEHC) develops, manufactures, and markets products, services, and digital solutions used in the diagnosis, treatment, and monitoring of patients. While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Menopause Market Size, Share & Trends Analysis Report and Growth Forecasts 2025-2030: Menopause Market Projected To Reach $24.35 Billion By 2030 With A 5.42% CAGR
The Menopause Market is projected to reach USD 24.35 billion by 2030, growing at a CAGR of 5.42%. Market drivers include increasing menopause awareness, dietary supplement research, and FDA drug approvals. Key players like Morphus and Amyris, Inc. are innovating treatments, while regions like North America see high demand for nutrients in older women. The comprehensive report offers market intelligence, forecasts, and trends for informed decision-making. Menopause Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), Region (NA, Europe, APAC, Latin America, MEA) with Growth Forecasts, 2025-2030" report has been added to Menopause Market was valued at USD 17.79 billion in 2024, and is projected to reach USD 24.35 billion by 2030, rising at a CAGR of 5.42%. The market growth is expected to be driven by factors such as rising prevalence of post-menopausal syndrome, increasing awareness regarding menopause-associated health aspects, and high adoption of women's health apps. The market is projected to be driven by rising research supporting the benefits of dietary supplements over HRT. Many dietary supplements are available in the market that contain ingredients such as black cohosh, red clover, soy isoflavones, and amberen. Manufacturers are also involved in developing new products to address menopausal symptoms. For instance, Morphus launched several supplement products in 2023 to address some of the most pressing symptoms of menopause and perimenopause. The first product launched was FiberUs, an unflavored soluble prebiotic fiber made from guar demand for dietary supplements and OTC pharma products increased in the post-pandemic scenario due to the delays in physician's appointments, rescheduling of hormonal replacement therapies, and the easy availability of OTC drugs from retail pharmacies and online channels. However, the market is now stabilizing due to the ease of restrictions and the increasing awareness of surge in FDA approvals for drugs aimed at treating hot flashes and night sweats is a significant factor propelling the growth of the market. In May 2023, the FDA gave their approval for a new non-hormonal medication to address night sweats and hot flashes that are often experienced by individuals during menopause. This prescription drug, called fezolinetant, is specifically designed for those who are unable to take hormonal therapy and who are struggling with vasomotor symptoms, such as breast cancer survivors. The medication is branded under the name Market Report Highlights Based on treatment, the dietary supplements treatment segment dominated the market in 2024 and is expected to witness the fastest growth during the forecast period. The growth of the segment can be attributed to several factors, including the increasing geriatric population and the launch of innovative products. For instance, in April 2021, Pulmuone, a South Korea-based dietary supplement firm, introduced a product that contains soybean and hop extracts for the treatment of menopause-related symptoms The OTC pharmaceutical products treatment segment is categorized into non-hormonal and hormonal products. Women undergoing menopause are increasingly using over-the-counter (OTC) hormone products. Major products in this segment include topical progesterone, ibuprofen, Dehydroepiandrosterone (DHEA), and melatonin North America held the largest revenue share in 2024. There is a growing awareness about dietary requirements, which is leading to a greater demand among older women for specific nutritional needs In January 2022, Amyris, Inc. announced that it has entered into exclusive agreements to acquire the assets of a women-founded company MenoLabs, LLC. that focuses on treating menopause symptoms, conducting research of women's health and increasing society's understanding of menopause In January 2023, O Positiv, a women's health brand, launched the first-ever menopause gummy vitamin, providing menopausal women with a convenient and tasty way to manage their symptoms This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Companies Featured The major companies featured in this Menopause market report include: Bayer AG Theramex AbbVie, Inc. Pure Encapsulations, LLC Dr. Reddy's Laboratories Ltd. ReNew Life Holdings Corporation Padagis Key Attributes: Report Attribute Details No. of Pages 210 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $17.79 Billion Forecasted Market Value (USD) by 2030 $24.35 Billion Compound Annual Growth Rate 5.4% Regions Covered Global Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Menopause Market Variables, Trends & Scope3.1. Market Lineage Outlook3.1.1. Parent market outlook3.2. Market Dynamics3.2.1. Market driver analysis3.2.1.1. A growing number of women experiencing menopause3.2.1.2. Increasing awareness regarding the treatment of menopausal symptoms3.2.1.3. Innovation in products available for the management of Menopause3.2.1.4. Increasing research supporting the advantages of dietary supplements3.2.2. Market restraint analysis3.2.2.1. Social stigma associated with menopause and adverse effects of products3.2.2.2. Lack of well-defined regulations3.3. Qualitative Analysis Impact of COVID-19 on Menopause Market3.4. List of Products3.5. Business Environment AnalysisChapter 4. Menopause Market Segment Analysis, By Treatment, 2018-2030 (USD Million)4.1. Menopause Market: Treatment Movement Analysis and Market Share4.2. Menopause Market: Treatment Segment Dashboard4.3. Dietary Supplements4.4. OTC Pharma Products4.4.1. OTC pharma products market, 2018-2030 (USD Million)4.4.2. Hormonal Products4.4.3. Non-hormonal productsChapter 5. Region, By Treatment, 2018-2030 (USD Million)5.1. Regional Market Dashboard5.2. Regional marketplace: Key takeawaysChapter 6. Competitive Landscape6.1. Recent Developments & Impact Analysis, By Key Market Participants6.2. Company Categorization6.3. Vendor Landscape6.4. Company Profiles For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Menopause Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
